Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (21)
Junhui Park & Seung-Ho Kang. (2022) Hierarchical Generalized Linear Models for Multiregional Clinical Trials. Statistics in Biopharmaceutical Research 14:3, pages 358-367.
Read now
Read now
Feng-shou Ko. (2022) Comparisons of a multi-regional trial for four or five regions by fixed effect model and random effect model about allocating sample size rationally into individual regions for a multi-regional trial. Communications in Statistics - Theory and Methods 0:0, pages 1-21.
Read now
Read now
Shuhei Kaneko & Akihiro Hirakawa. (2021) Assessment of Overall Treatment Effect in the Presence of Inconsistent Regional Effects in Multiregional Clinical Trials. Statistics in Biopharmaceutical Research 13:2, pages 219-229.
Read now
Read now
Makoto Aoki, Hisashi Noma & Masahiko Gosho. (2021) Methods for detecting outlying regions and influence diagnosis in multi-regional clinical trials. Biostatistics & Epidemiology 5:1, pages 30-48.
Read now
Read now
Saemina Kim & Seung-Ho Kang. (2020) Hierarchical Linear Models for Multiregional Clinical Trials. Statistics in Biopharmaceutical Research 12:3, pages 334-343.
Read now
Read now
Feng-shou Ko. (2020) An alternate approach for sample size determination in a multi-regional trial. Communications in Statistics - Theory and Methods 49:4, pages 997-1007.
Read now
Read now
Zhaoyang Teng, Jianchang Lin & Bin Zhang. (2018) Practical Recommendations for Regional Consistency Evaluation in Multi-Regional Clinical Trials with Different Endpoints. Statistics in Biopharmaceutical Research 10:1, pages 50-56.
Read now
Read now
William Wang, Zhiwei Jiang, Jingjun Qiu, Jielai Xia & Xiang Guo. (2017) A nested group sequential framework for regional evaluation in global drug development program. Journal of Biopharmaceutical Statistics 27:6, pages 945-962.
Read now
Read now
Zhaoyang Teng, Yeh-Fong Chen & Mark Chang. (2017) Unified additional requirement in consideration of regional approval for multiregional clinical trials. Journal of Biopharmaceutical Statistics 27:6, pages 903-917.
Read now
Read now
Yijie Zhou, Lu Cui, Bo Yang, Lanju Zhang & Frank Shen. (2017) Regional efficacy assessment in multiregional clinical development. Journal of Biopharmaceutical Statistics 27:4, pages 673-682.
Read now
Read now
Feng-shou Ko. (2016) Comparisons of allocating sample size rationally into individual regions under heterogeneous effect size in a multiregional trial by a fixed effect model and a random effect model. Communications in Statistics - Theory and Methods 45:23, pages 7060-7074.
Read now
Read now
Feng-Shou Ko. (2015) Sample Size Determination and Rational Partition for A Multi- Regional Trial for Survival (Time-To-Event) Data with Unrecognized Heterogeneity that Interacts with Treatment. Communications in Statistics - Theory and Methods 44:3, pages 486-496.
Read now
Read now
Feng-Shou Ko. (2014) An Approach to Determine Sample Size and to Allocate Sample Size for a Specific Region in a Multiregional Trial for Survival (Time-to-Event) Data under Accelerated Failure Time Model. Communications in Statistics - Theory and Methods 43:23, pages 4925-4935.
Read now
Read now
Yuh-Jenn Wu, Te-Sheng Tan, Shein-Chung Chow & Chin-Fu Hsiao. (2014) Sample Size Estimation of Multiregional Clinical Trials with Heterogeneous Variability Across Regions. Journal of Biopharmaceutical Statistics 24:2, pages 254-271.
Read now
Read now
JamesD. Stamey, Fanni Natanegara & JohnW. Seaman$suffix/text()$suffix/text(). (2013) Bayesian Sample Size Determination for a Clinical Trial with Correlated Continuous and Binary Outcomes. Journal of Biopharmaceutical Statistics 23:4, pages 790-803.
Read now
Read now
Feng-shou Ko. (2013) A Design For Survival Studies: A Multi-regional Trial With Unrecognized Heterogeneity. Communications in Statistics - Theory and Methods 42:13, pages 2301-2323.
Read now
Read now
Feng-shou Ko. (2012) Approaches to Allocate Sample Size Rationally Into Individual Regions for a Multi-regional Trial Under Heterogeneous Effect Size. Communications in Statistics - Theory and Methods 41:20, pages 3648-3665.
Read now
Read now
Yi Tsong. (2012) Statistical Considerations on Design and Analysis of Bridging and Multiregional Clinical Trials. Journal of Biopharmaceutical Statistics 22:5, pages 1078-1080.
Read now
Read now
Chi-Tian Chen, H.M. James Hung & Chin-Fu Hsiao. (2012) Design and Evaluation of Multiregional Trials with Heterogeneous Treatment Effect Across Regions. Journal of Biopharmaceutical Statistics 22:5, pages 1037-1050.
Read now
Read now
Yi Tsong, Wan-Jung Chang, Xiaoyu Dong & Hsiao-Hui Tsou. (2012) Assessment of Regional Treatment Effect in a Multiregional Clinical Trial. Journal of Biopharmaceutical Statistics 22:5, pages 1019-1036.
Read now
Read now
Xiaoyuan Chen, Nelson Lu, Rajesh Nair, Yunling Xu, Cailian Kang, Qin Huang, Ning Li & Hongzhuan Chen. (2012) Decision Rules and Associated Sample Size Planning for Regional Approval Utilizing Multiregional Clinical Trials. Journal of Biopharmaceutical Statistics 22:5, pages 1001-1018.
Read now
Read now
Articles from other publishers (24)
Nathan W Bean, Joseph G Ibrahim & Matthew A Psioda. (2023) Bayesian multiregional clinical trials using model averaging. Biostatistics 24:2, pages 262-276.
Crossref
Crossref
Yuh‐Jenn Wu, Yu‐Chieh Cheng, Chieh Chiang, Li‐Hsueh Cheng, Ching‐Ti Liu & Chin‐Fu Hsiao. (2021) Use of likelihood estimates for variances for the design and evaluation of multiregional clinical trials with heterogeneous variances. Statistics in Medicine 41:1, pages 87-107.
Crossref
Crossref
Sisay W. Adall & Jin Xu. (2021) Bayes shrinkage estimator for consistency assessment of treatment effects in multi‐regional clinical trials. Pharmaceutical Statistics 20:6, pages 1074-1087.
Crossref
Crossref
Si‐Cheng Wu, Jin‐Fang Xu, Xin‐Ji Zhang, Zhi‐Wei Li & Jia He. (2020) Regional consistency and sample size considerations in a multiregional equivalence trial. Pharmaceutical Statistics 19:6, pages 897-908.
Crossref
Crossref
Seung-Ho Kang & Saemina Kim. (2018) Statistical implications of extrapolating the overall result to the target region in multi-regional clinical trials. Communications for Statistical Applications and Methods 25:4, pages 341-354.
Crossref
Crossref
Ian Wadsworth, Lisa V Hampson & Thomas Jaki. (2016) Extrapolation of efficacy and other data to support the development of new medicines for children: A systematic review of methods. Statistical Methods in Medical Research 27:2, pages 398-413.
Crossref
Crossref
Chi-Tian Chen, Hsiao-Hui Tsou, Jung-Tzu Liu, Chin-Fu Hsiao, Fei Chen, Gang Li & K. K. G. Lan. 2018. Biopharmaceutical Applied Statistics Symposium. Biopharmaceutical Applied Statistics Symposium
269
286
.
Wong-Shian Huang, Hui-Nien Hung, Toshimitsu Hamasaki & Chin-Fu Hsiao. (2017) Sample size determination for a specific region in multiregional clinical trials with multiple co-primary endpoints. PLOS ONE 12:6, pages e0180405.
Crossref
Crossref
Jung-Tzu Liu, Hsiao-Hui Tsou, K. K. Gordon LanChi-Tian Chen, Yi-Hsuan Lai, Wan-Jung Chang, Chyng-Shyan Tzeng & Chin-Fu Hsiao. (2016) Assessing the consistency of the treatment effect under the discrete random effects model in multiregional clinical trials. Statistics in Medicine 35:14, pages 2301-2314.
Crossref
Crossref
Zhaoyang Teng, Jianchang Lin & Bin Zhang. 2016. Statistical Applications from Clinical Trials and Personalized Medicine to Finance and Business Analytics. Statistical Applications from Clinical Trials and Personalized Medicine to Finance and Business Analytics
107
120
.
Jung-Tzu Liu, Chi-Tian Chen, K. K. Gordon Lan, Chyng-Shyan Tzeng, Chin-Fu Hsiao & Hsiao-Hui Tsou. 2016. Statistical Applications from Clinical Trials and Personalized Medicine to Finance and Business Analytics. Statistical Applications from Clinical Trials and Personalized Medicine to Finance and Business Analytics
127
136
.
Shein‐Chung Chow & Jen‐Pei Liu. 2013. Design and Analysis of Clinical Trials. Design and Analysis of Clinical Trials
799
844
.
Yufen Huang, Wan-Jung Chang & Chin-Fu Hsiao. (2013) An empirical Bayes approach to evaluation of results for a specific region in multiregional clinical trials. Pharmaceutical Statistics 12:2, pages 59-64.
Crossref
Crossref
Yuh-Jenn Wu, Te-Sheng Tan, Shein-Chung Chow & Chin-Fu Hsiao. 2013. Topics in Applied Statistics. Topics in Applied Statistics
325
334
.
Jen-pei Liu, Shein-Chung Chow & Chin-Fu HsiaoWeichung Shih & Hui Quan. 2012. Design and Analysis of Bridging Studies. Design and Analysis of Bridging Studies
33
48
.
Jen-pei Liu, Shein-Chung Chow & Chin-Fu HsiaoShein-Chung Chow & Chin-Fu Hsiao. 2012. Design and Analysis of Bridging Studies. Design and Analysis of Bridging Studies
1
16
.
Jen-pei Liu, Shein-Chung Chow & Chin-Fu HsiaoYi Tsong & Hsiao-Hui Tsou. 2012. Design and Analysis of Bridging Studies. Design and Analysis of Bridging Studies
219
234
.
Jen-pei Liu, Shein-Chung Chow & Chin-Fu HsiaoEric Hsieh & Jen-pei Liu. 2012. Design and Analysis of Bridging Studies. Design and Analysis of Bridging Studies
197
218
.
Hsiao-Hui Tsou, H. M. James Hung, Yue-Ming Chen, Wong-Shian Huang, Wan-jung Chang & Chin-Fu Hsiao. (2012) Establishing consistency across all regions in a multi-regional clinical trial. Pharmaceutical Statistics 11:4, pages 295-299.
Crossref
Crossref
Shein-Chung Chow. (2011) Sample size calculations for clinical trials. Wiley Interdisciplinary Reviews: Computational Statistics 3:5, pages 414-427.
Crossref
Crossref
Hsiao‐Hui Tsou, Tuan‐Ying Chien, Jen‐pei Liu & Chin‐Fu Hsiao. (2011) A consistency approach to evaluation of bridging studies and multi‐regional trials. Statistics in Medicine 30:17, pages 2171-2186.
Crossref
Crossref
Shein-Chung Chow. 2011. Controversial Statistical Issues in Clinical Trials. Controversial Statistical Issues in Clinical Trials
553
576
.
Shein-Chung Chow & Chin-Fu Hsiao. (2012) Bridging Diversity. Pharmaceutical Medicine 24:6, pages 349-362.
Crossref
Crossref
Hsiao-Hui Tsou, Shein-Chung Chow, K. K. Gordon Lan, Jen-pei Liu, Mey Wang, Herng-Der Chern, Low-Tone Ho, Chao A. Hsiung & Chin-Fu Hsiao. (2010) Proposals of statistical consideration to evaluation of results for a specific region in multi-regional trials - Asian perspective. Pharmaceutical Statistics 9:3, pages 201-206.
Crossref
Crossref